NCT07453147 (MCATTs) is a NA clinical trial of Selective/Segmented graft in Gum Recession, sponsored by Centre Hospitalier Universitaire de Liege.

Who is sponsoring NCT07453147?

NCT07453147 is sponsored by Centre Hospitalier Universitaire de Liege.

What drugs are being tested in NCT07453147?

Interventions in NCT07453147: Selective/Segmented graft, Continuous graft.

What condition does NCT07453147 study?

NCT07453147 studies Gum Recession.

Is NCT07453147 still recruiting?

NCT07453147 is currently recruiting now. Last updated 5 March 2026.

Last reviewed 2026-03-05 · How we verify

NCT07453147: MCATTs

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Selective Versus Contiguous Connective Tissue Grafts in the Modified Tunnel Technique

Recruiting now NA Last updated 5 March 2026

What this trial tests

NA trial testing Selective/Segmented graft in Gum Recession in 32 participants. Currently enrolling.

Timeline

1 September 2025

Primary endpoint
1 September 2028

1 September 2028

Quick facts

Lead sponsor	Centre Hospitalier Universitaire de Liege
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	32
Start date	1 September 2025
Primary completion	1 September 2028
Estimated completion	1 September 2028
Sites	2 locations across Belgium, France

Drugs / interventions tested

Selective/Segmented graft
Continuous graft

Conditions studied

Gum Recession — all drugs for Gum Recession →

Sponsor

Centre Hospitalier Universitaire de Liege

Who can join

18 and older, any sex, with Gum Recession. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to evaluate how effective a gum grafting procedure is in treating gum recession that affects several teeth. Gum recession happens when the gum tissue pulls away from the tooth, exposing the roots. The study will look at how the treatment improves gum health, appearance, and function. A total of 32 patients will take part in the study. All patients will be treated with a modified coronally advanced tunnel. For half of them of contiguous graft will be used, for the other half a segmented graft. Data collected will include medical history, dental and aesthetic information, clinical measurements, and a digital scan of the mouth. The study will include the following steps: Before the procedure: You will have a clinical and X-ray examination to determine how much your gums have receded. A digital impression of your teeth will also be taken. Surgical procedure: You will receive a gum graft to cover the exposed roots. This involves moving gum tissue, often taken from the roof of your mouth, to the affected areas. After the procedure: You will have several follow-up visits over a few months to check your healing and the results of the treatment. Study timeline: The surgery will be done once. Follow-up visits will take place 1, 3, 6, and 12 months after the surgery. The total duration of the study is about 12 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Centre Hospitalier Universitaire de Liege trials

Trials by the same sponsor.

NCT07408362 — Early Diagnosis and Cardiovascular Risk Stratification in Children Exposed to Cancer Therapies · NA · not yet recruiting
NCT07159555 — Assessment of Neurofilaments Levels in Premature Newborns: Study of Their Early Development · recruiting
NCT07031518 — Pilot Study to Identify and Validate Digital Biomarkers in Osteoarthritis of the Knee · NA · completed
NCT06916871 — Optimizing Care for Diabetic Patients in Hospitalized Rehabilitation Through Structured Education · NA · not yet recruiting
NCT07074405 — Acceptability of Artificial Intelligence in the Diagnosis of Prostate Cancer · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07453147 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Liege
Last refreshed: 5 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07453147.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing